Stem Cell Differentiation via Hypoxic Culture Conditions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating pluripotent stem cells, such as embryonic stem cells, into cardiomyocytes face challenges in producing sufficient numbers for clinical transplantation due to the need for donor cells and the inefficiency of existing differentiation protocols, which often require exogenous growth factors and optimal oxygen conditions.
Innovation Solution
Modulating oxygen levels during the culture and differentiation of pluripotent stem cells, specifically by maintaining low oxygen conditions initially and potentially increasing oxygen later, enhances differentiation towards mesoderm and endoderm lineages without the need for exogenous growth factors, resulting in increased production of cardiomyocytes and other cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional differentiation protocols are used with exogenous growth factors and normoxic conditions, then differentiation can be achieved, but the yield and efficiency of cardiomyocyte production is insufficient for clinical needs
Solution Approach 1:
The patent changes the oxygen concentration parameter from conventional normoxic (20% O2) to hypoxic (3-5% O2) conditions during ES cell differentiation. This parameter change alone significantly enhances cardiomyocyte yield without requiring additional growth factors or complex protocol modifications, directly resolving the contradiction between productivity and ease of manufacture
Solution Approach 2:
The patent eliminates the need for exogenous growth factors by using hypoxic conditions to naturally drive differentiation. The system becomes self-sufficient, where the oxygen level itself serves as the differentiating signal, removing the need for external additives and simplifying the manufacturing process while increasing efficiency
2Quantity of substance
If donor cells are obtained through organ donation, then transplantation can be performed, but there is always a shortage of donor cells and tissue
Solution Approach 1:
The patent creates copies of cardiomyocytes by differentiating pluripotent stem cells into cardiomyocytes in vitro. This copying process generates large numbers of genetically identical or similar cells that can be used for transplantation, eliminating the shortage of donor cells while maintaining reliability through controlled laboratory production
3Productivity
If ES cell differentiation is performed under normoxic conditions, then standard culture protocols can be used, but the differentiation efficiency towards mesoderm and endoderm lineages is reduced
Solution Approach 1:
The patent modifies the oxygen concentration parameter to hypoxic levels (3-5% O2) to enhance differentiation efficiency towards mesoderm and endoderm lineages. This single parameter change improves productivity without significantly increasing device complexity, as standard incubators can be configured to maintain these oxygen levels
Data Source
AI summary
The invention provides methods for differentiating pluripotent stem cells such as ES cells with improved progenitor and differentiated cell yield using low oxygen conditions and optionally in the absence of exogenously added differentiation factors.